Prados, M. D., Chang, S. M., Butowski, N., DeBoer, R., Parvataneni, R., Carliner, H., . . . Haas-Kogan, D. A. (2009). Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma. American Society of Clinical Oncology.
শিকাগো স্টাইলে সাইটেশনPrados, Michael D., et al. Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma. American Society of Clinical Oncology, 2009.
এমএলএ সাইটেশনPrados, Michael D., et al. Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma. American Society of Clinical Oncology, 2009.